IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).

Alphabet ranks 15th among 7,300 stocks with a near-perfect stability score of 98. At 21 times earnings with 16 percent revenue growth and almost no debt, the model sees something the consensus is underpricing.

A six-factor quantitative model scanning 7,300 U.S. stocks has surfaced a surprising top 10 — led by a $300 million medical device company most investors have never heard of. Alphabet sits at 15. Here is what the data says.
Our Entry Timing signal uses 5 peer-reviewed factors from top finance journals — no black-box scoring. Here's the research behind each signal.